RFP - Supply of pegylated interferon, pegylated interferon with ribavirin, boceprevir and telaprevir
PHARMAC invites proposals for the supply of pegylated interferon, pegylated interferon with ribavirin, boceprevir and telaprevir in New Zealand.
The request for proposals (RFP) letter below incorporates the following schedules:
- Schedule 1 specifies the pharmaceutical for which PHARMAC is requesting proposals and sets out the background to the RFP and the types of proposals sought;
- Schedule 2 describes the process that PHARMAC expects to follow in relation to the RFP;
- Schedule 3 sets out information about the estimated size of the current subsidised market for the pharmaceuticals; and
- Schedule 4 contains the RFP form in which you are to provide details of your proposal.
If you wish to submit a proposal, you must submit it to PHARMAC no later than 4:30 p.m. on 10 June 2013.
If you have any questions about this RFP, please contact Greg Williams at PHARMAC by telephone (04) 916-7524 or email email@example.com.